Natera, Inc. (NTRA) stock

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30152% above fair value

$319.09−3.85 (-1.19%)

Close on Nov 13, 2026Market cap $46.00BP/E –Yield –

Natera gross margin

Gross margin is gross profit as a percentage of revenue.

Natera's gross margin for the twelve months ending Jun 30, 2020 was 49.5%. For fiscal 2018 it was 38.6%, against 35.4% the year before. The highest annual figure on record is 50.8% in fiscal 2014.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2018	Dec 31, 2018	38.6%	+3.3
FY2017	Dec 31, 2017	35.4%	−1.4
FY2016	Dec 31, 2016	36.7%	−4.0
FY2015	Dec 31, 2015	40.7%	−10.1
FY2014	Dec 31, 2014	50.8%	+18.3
FY2013	Dec 31, 2013	32.4%	–

Quarterly gross margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2020	Jun 30, 2020	50.6%	+9.5
Q1 FY2020	Mar 31, 2020	55.8%	+20.6
Q4 FY2019	Dec 31, 2019	46.6%	+10.5
Q3 FY2019	Sep 30, 2019	43.7%	+7.5
Q2 FY2019	Jun 30, 2019	41.1%	+6.1
Q1 FY2019	Mar 31, 2019	35.2%	+0.3
Q4 FY2018	Dec 31, 2018	36.1%	+6.7
Q3 FY2018	Sep 30, 2018	36.2%	−1.9
Q2 FY2018	Jun 30, 2018	35.0%	+1.1
Q1 FY2018	Mar 31, 2018	34.9%	+3.1
Q4 FY2017	Dec 31, 2017	29.4%	+6.5
Q3 FY2017	Sep 30, 2017	38.1%	–
Q2 FY2017	Jun 30, 2017	33.9%	–
Q1 FY2017	Mar 31, 2017	31.8%	–
Q4 FY2016	Dec 31, 2016	22.9%	–